Literature DB >> 19954683

A new pathogenetic treatment for symptomatic diabetic polyneuropathy?

Andrew J M Boulton.   

Abstract

Entities:  

Year:  2009        PMID: 19954683     DOI: 10.1007/s11892-009-0066-x

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


× No keyword cloud information.
  11 in total

Review 1.  Diabetic somatic neuropathies.

Authors:  Andrew J M Boulton; Rayaz A Malik; Joseph C Arezzo; Jay M Sosenko
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

Review 2.  Diabetic neuropathies: a statement by the American Diabetes Association.

Authors:  Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2005-04       Impact factor: 19.112

3.  Improvement of glucose metabolism in patients with type II diabetes after treatment with a hemodialysate.

Authors:  S Jacob; G J Dietze; F Machicao; G Kuntz; H J Augustin
Journal:  Arzneimittelforschung       Date:  1996-03

4.  The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes.

Authors:  Mark Davies; Sinead Brophy; Rhys Williams; Ann Taylor
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

5.  Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial.

Authors:  Nigishi Hotta; Yasuo Akanuma; Ryuzo Kawamori; Kempei Matsuoka; Yoshitomo Oka; Motoaki Shichiri; Takayoshi Toyota; Mitsuyoshi Nakashima; Isao Yoshimura; Nobuo Sakamoto; Yukio Shigeta
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

6.  Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial.

Authors:  R A Malik; S Williamson; C Abbott; A L Carrington; J Iqbal; W Schady; A J Boulton
Journal:  Lancet       Date:  1998 Dec 19-26       Impact factor: 79.321

7.  Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3.

Authors:  Dan Ziegler; Wolfgang Rathmann; Thorsten Dickhaus; Christa Meisinger; Andreas Mielck
Journal:  Diabetes Care       Date:  2007-11-26       Impact factor: 19.112

Review 8.  Painful diabetic neuropathy: treatment and future aspects.

Authors:  Dan Ziegler
Journal:  Diabetes Metab Res Rev       Date:  2008 May-Jun       Impact factor: 4.876

9.  Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.

Authors:  S Kanowski; E Kinzler; E Lehmann; A Schweizer; G Kuntz
Journal:  Pharmacopsychiatry       Date:  1995-07       Impact factor: 5.788

10.  Ranirestat for the management of diabetic sensorimotor polyneuropathy.

Authors:  Vera Bril; Toshiyuki Hirose; Sasagu Tomioka; Robert Buchanan
Journal:  Diabetes Care       Date:  2009-04-14       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.